Jasper Therapeutics (JSPR) Q4 2024 Earnings Report

1,064 Followers

JSPR Q4 2024 EPS Results

Actual EPS-$1.62

Consensus EPS-$1.25

Beat/MissMissed by -$0.37

One Year Ago EPS-$1.50

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2024

Date02/27/2025

TimeBefore Open

Conference CallThursday, February 27, 2025

JSPR Upcoming Earnings

Jasper Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.08 / -	-1.13	―
Aug 14, 2026	2026 (Q2)	-0.27 / -0.10	-1.74	94.25% (+1.64)
May 14, 2026	2026 (Q1)	-0.49 / -0.04	-1.41	97.16% (+1.37)
Mar 30, 2026	2025 (Q4)	-0.80 / -0.32	-1.62	80.25% (+1.30)
Nov 10, 2025	2025 (Q3)	-1.22 / -1.13	-1.24	8.87% (+0.11)
Aug 13, 2025	2025 (Q2)	-1.33 / -1.74	-0.97	-79.38% (-0.77)
May 12, 2025	2025 (Q1)	-1.35 / -1.41	-1.03	-36.89% (-0.38)
Feb 27, 2025	2024 (Q4)	-1.25 / -1.62	-1.5	-8.00% (-0.12)
Nov 07, 2024	2024 (Q3)	-1.07 / -1.24	-1.6	22.50% (+0.36)
Aug 13, 2024	2024 (Q2)	-1.09 / -0.97	-1.5	35.33% (+0.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed